title: Retrobulbar optic neuritis: a complication of Lyme disease?
authors.forename: E
authors.initials: E
authors.lastname: Krim
authors.forename: D
authors.initials: D
authors.lastname: Guehl
authors.forename: P
authors.initials: P
authors.lastname: Burbaud
authors.forename: A
authors.initials: A
authors.lastname: Lagueny
mesh_terms: D000208:Acute Disease; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015153:Blotting, Western; D001899:Borrelia Infections / Q000150:complications / Q000188:drug therapy / Q000276:immunology; D025065:Borrelia burgdorferi / Q000302:isolation & purification; D002443:Ceftriaxone / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D008193:Lyme Disease / Q000150:complications* / Q000276:immunology / Q000382:microbiology; D008297:Male; D009902:Optic Neuritis / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology; D012607:Scotoma / Q000175:diagnosis / Q000209:etiology; D014792:Visual Acuity / Q000502:physiology
chemical_list: D000900:Anti-Bacterial Agents; D007074:Immunoglobulin G; D002443:Ceftriaxone